Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
4.42
Dollar change
+0.37
Percentage change
9.14
%
Index- P/E- EPS (ttm)-2.10 Insider Own24.56% Shs Outstand17.90M Perf Week11.62%
Market Cap93.57M Forward P/E- EPS next Y-1.23 Insider Trans0.00% Shs Float15.97M Perf Month-10.34%
Income-35.57M PEG- EPS next Q-0.31 Inst Own21.75% Short Float4.18% Perf Quarter-22.73%
Sales0.00M P/S- EPS this Y60.96% Inst Trans2.36% Short Ratio7.06 Perf Half Y-9.43%
Book/sh0.19 P/B23.17 EPS next Y21.56% ROA-148.03% Short Interest0.67M Perf Year-8.11%
Cash/sh0.94 P/C4.70 EPS next 5Y15.00% ROE-1399.88% 52W Range3.03 - 10.30 Perf YTD7.28%
Dividend Est.- P/FCF- EPS past 5Y60.98% ROI-175.62% 52W High-57.09% Beta1.33
Dividend TTM- Quick Ratio5.36 Sales past 5Y0.00% Gross Margin- 52W Low45.87% ATR (14)0.32
Dividend Ex-Date- Current Ratio5.36 EPS Y/Y TTM47.37% Oper. Margin0.00% RSI (14)51.56 Volatility10.11% 6.86%
Employees20 Debt/Eq4.03 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price24.57
Option/ShortYes / Yes LT Debt/Eq4.01 EPS Q/Q75.06% Payout- Rel Volume1.88 Prev Close4.05
Sales Surprise- EPS Surprise7.61% Sales Q/Q- EarningsNov 09 AMC Avg Volume94.49K Price4.42
SMA201.46% SMA503.04% SMA200-9.73% Trades Volume177,701 Change9.14%
Date Action Analyst Rating Change Price Target Change
May-10-23Reiterated Maxim Group Buy $8 → $20
Jun-23-21Initiated Oppenheimer Outperform $23
Feb-29-24 08:01AM
08:00AM
Dec-15-23 08:35AM
Dec-13-23 08:00AM
Dec-12-23 01:02PM
09:10AM Loading…
09:10AM
Dec-11-23 04:30PM
Nov-11-23 10:36AM
Nov-10-23 10:01AM
Nov-09-23 04:00PM
Oct-26-23 08:00AM
Oct-03-23 08:00AM
Sep-11-23 08:00AM
Sep-07-23 08:00AM
Aug-16-23 10:30AM
10:25PM Loading…
Aug-15-23 10:25PM
Aug-14-23 04:00PM
Aug-01-23 08:00AM
Jul-18-23 08:00AM
Jul-11-23 11:23AM
May-25-23 09:00AM
07:16AM
May-24-23 06:10AM
May-23-23 02:46PM
06:00AM
May-17-23 08:00AM
May-10-23 09:08AM
05:57AM
May-09-23 04:05PM
Apr-26-23 08:00AM
05:27AM Loading…
Apr-24-23 05:27AM
Apr-20-23 02:22PM
08:00AM
Apr-14-23 08:00AM
Mar-30-23 08:00AM
Mar-29-23 08:00AM
Mar-20-23 10:46PM
05:27AM
Mar-17-23 08:00AM
05:48AM
Mar-16-23 04:05PM
Mar-08-23 08:00AM
Mar-03-23 08:00AM
Mar-02-23 08:00AM
Feb-15-23 05:42AM
Feb-07-23 08:00AM
Feb-02-23 08:00AM
Jan-27-23 04:30PM
Jan-09-23 08:00AM
Dec-29-22 06:02AM
Dec-21-22 08:00AM
Nov-21-22 06:01AM
Nov-15-22 08:00AM
Nov-14-22 04:05PM
Nov-08-22 08:00AM
Oct-31-22 08:00AM
Sep-27-22 08:00AM
Sep-07-22 08:00AM
Aug-15-22 06:16AM
Aug-11-22 04:05PM
Jul-28-22 08:00AM
Jul-01-22 04:05PM
Jun-29-22 08:00AM
Jun-21-22 08:00AM
Jun-01-22 08:00AM
May-26-22 08:00AM
May-16-22 01:20PM
May-13-22 08:00AM
06:30AM
May-12-22 04:00PM
May-05-22 02:59PM
Apr-28-22 05:22AM
Apr-27-22 09:40AM
08:00AM
Apr-21-22 08:00AM
Mar-15-22 08:00AM
Mar-14-22 08:00AM
Mar-11-22 08:06AM
08:00AM
Mar-10-22 08:00AM
Mar-08-22 08:00AM
Feb-24-22 08:00AM
Feb-04-22 04:37AM
Feb-03-22 08:00AM
Feb-02-22 08:00AM
Jan-28-22 10:07AM
Jan-25-22 11:08AM
08:00AM
Jan-06-22 08:30AM
Jan-04-22 08:30AM
Dec-22-21 12:16PM
08:30AM
Nov-23-21 08:30AM
Nov-22-21 08:30AM
Nov-11-21 04:20AM
03:00AM
Nov-09-21 04:05PM
Nov-04-21 08:30AM
Nov-02-21 01:03PM
08:30AM
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bencich JohnCEOMay 30Buy5.505,00027,50066,730Jun 01 05:42 PM
JACOBS CINDYPresident & CMOApr 28Option Exercise0.002,500018,870May 01 05:54 PM
Wan JerryPrincipal Accounting OfficerApr 28Option Exercise0.001,25007,101May 01 05:55 PM
Bencich JohnCEOApr 28Option Exercise0.007,500063,557May 01 05:53 PM
Stewart Richard AlistairExecutive ChairmanApr 28Option Exercise0.005,000030,751May 01 05:51 PM
Wan JerryPrincipal Accounting OfficerApr 21Option Exercise0.005,62508,861Apr 24 04:17 PM
Stewart Richard AlistairExecutive ChairmanApr 21Option Exercise0.0022,500035,876Apr 24 04:15 PM
JACOBS CINDYPresident & CMOApr 21Option Exercise0.0016,250020,181Apr 24 04:14 PM
Bencich JohnCEOApr 21Option Exercise0.0025,000061,920Apr 24 04:13 PM